Table 7 Utilisation of anti-hypertensive medicines among T2DM patients

127.1 ± 4.09

130.5 ± 3.45

3.34 (−7.33 to 14.01)

0.534

2.63

150.2 ± 7.99

154.6 ± 7.21

4.46 (−18.02 to 26.92)

0.683

2.96

130.1 ± 3.04

130.0 ± 4.36

0.01 (−10.74 to 10.74)

>0.999

0.00

130.4 ± 3.93

128.0 ± 3.59

−2.47 (−13.12 to 8.19)

0.644

−1.90

150.6 ± 9.07

176.6 ± 8.33

26.0 (−2.43 to 54.43)

0.061

17.30

153.3 ± 5.74

151.7 ± 4.98

−1.58 (−16.88 to 13.72)

0.835

1.03

143.1 ± 3.33

142.9 ± 3.46

−0.19 (−9.83 to 9.46)

0.969

0.13

DBP (mmHg)

74.87 ± 2.25

77.87 ± 1.80

3.00 (−2.75 to 8.74)

0.301

4.00

83.18 ± 3.74

83.55 ± 3.23

0.36 (−9.95 to 10.68)

0.942

0.43

80.00 ± 2.31

80.02 ± 2.09

1.00 (−5.29 to 7.30)

0.750

1.25

80.01 ± 1.89

76.43 ± 2.37

−4.67 (−10.73 to 1.40)

0.128

5.76

93.80 ± 5.23

104.4 ± 7.22

10.6 (−9.96 to 31.16)

0.086

11.30

86.13 ± 3.33

86.08 ± 2.62

−0.04 (−8.58 to 8.50)

0.992

0.05

82.81 ± 2.78

84.41 ± 2.40

1.59 (−5.78 to 8.96)

0.666

1.92